The Life Sciences Group is a global team of professionals whose focus is advising clients in the life sciences industries which includes the fields of biotechnology, pharmaceuticals, biomedical technologies, life systems technologies, nutraceuticals, environmental and biomedical devices.
Making the correct real estate decisions means being in the right location, at the right cost and at the right time for your staff, your clients and your business. Our Life Sciences Group shares best practice, research and knowledge from the real estate industry to assist in all aspects of a life science company’s real estate needs.
Life Sciences Real Estate Challenges
The sector has witnessed a downturn in recent years. Fewer start ups, patent expirations of well-known drugs, the global economic and market shifts, technology changes, increasing pressure from investors for return on equity, a decline in public funding and outsourcing of former core business functions have all impacted the industry. Some further challenges include:
- Expansion and scaling-up commercial operations
- Attracting top scientific talent
- Adapting RE needs to meet emerging therapeutic fields
- Migrating to lower cost environments
- Shedding unneeded obligations
- Monetizing underutilised assets
How Can We Add Value?
The fundamental real estate challenge for the life sciences company is to ensure the greatest measure of flexibility for its expensive, highly specialized, long-term fixed assets.
The Life Sciences Group offers industry leaders a partner in meeting these challenges. Our professionals have decades of experience covering all sectors - pharmaceutical, biopharmaceutical, biotechnology, and medical devices - and all asset classes - R&D, manufacturing, distribution, and office. With clients spanning four continents, we help to leverage the global market and effectively navigate through a dynamic landscape in order to improve margins, maximize productivity, and remain competitive in every sector.
Drawing from this broad experience, our team of consultants and transaction specialists add a unique value by helping align real estate portfolios with company business goals. Some of the services we provide are as follows:
From real estate due diligence for merger and acquisition activity, to location analysis and portfolio optimization programs, our focus is helping you deliver your business objectives while reducing risk.
We help you optimize the value of your property while considering the impact on your firm’s balance sheet, implementing everything from global lease administration, lease abstraction and database management to strategic analysis and assist decision making.
Global lease administration
To help minimize the associated risks of managing your corporate portfolio, we provide you with the detailed business data you need to properly and intelligently implement your corporate strategy.
By implementing the ‘intelligent client’ role in managing transactions, our agents and brokers can advise and facilitate smoother transactions, whether it’s a full property search and relocation or simply a lease renewal.
Program and project management
We help you deliver real estate projects on time, within budget, and to specifications.
We deliver the quality of service that top-tier clients expect from their real estate firms, and we produce that quality of service within common-sense budgeting guidelines. We offer regional and global experience with global pharmaceutical, biopharmaceutical, biotechnology, and biomedical companies. The Practice also maintains partnerships with organizations dedicated to the advancement of the life sciences, including leading research-based companies, academic institutions, and government agencies.
Experience and Resources
Our Life Sciences clients benefit from an experienced research team, including a team of expert sector specialists in local markets around the world. We are also strengthened by our international network of nearly 15,000 professionals including researchers, strategists, business modellers, accountants, business consultants and agents in 253 offices across 60 countries.
We have a broad range of clients in the life sciences industry, including GE, GlaxoSmithKline, TEVA Pharmaceuticals, Sanofi-Aventis, Abbott Laboratories and Astra-Zeneca.